WELCOME

PDGF

PDGFB (22q13), Dermatofibrosarcoma Protuberans/Giant Cell Fibroblastoma, FISH, Tissue

88271x2, 88291-DNA probe, each (first probe set), Interpretation and report 88271x2-DNA probe, each; each additional probe set (if appropriate) 88271x1-DNA probe, each; coverage for sets containing 3 probes (if appropriate) 88271x2-DNA probe, each; coverage for sets containing 4 probes (if appropriate) 88271x3-DNA probe, each; coverage for sets containing 5 probes (if appropriate) 88274 w/modifier 52-Interphase in situ hybridization,

USPF

USP6 (17p13), Aneurysmal Bone Cyst and Nodular Fasciitis, FISH, Tissue

88271x2, 88291-DNA probe, each (first probe set), Interpretation and report 88271x2-DNA probe, each; each additional probe set (if appropriate) 88271x1-DNA probe, each; coverage for sets containing 3 probes (if appropriate) 88271x2-DNA probe, each; coverage for sets containing 4 probes (if appropriate) 88271x3-DNA probe, each; coverage for sets containing 5 probes (if appropriate) 88274 w/modifier 52-Interphase in situ hybridization,

MAMLF

MAML2 (11q21) Rearrangement, Mucoepidermoid Carcinoma (MEC), FISH, Tissue

88271x2, 88291-DNA probe, each (first probe set), Interpretation and report 88271x2-DNA probe, each; each additional probe set (if appropriate) 88271x1-DNA probe, each; coverage for sets containing 3 probes (if appropriate) 88271x2-DNA probe, each; coverage for sets containing 4 probes (if appropriate) 88271x3-DNA probe, each; coverage for sets containing 5 probes (if appropriate) 88274 w/modifier 52-Interphase in situ hybridization,

ATHL

Alpha-Globin Gene Analysis

81269

METF

MET (7q31), FISH, Tissue

88271x2, 88291-DNA probe, each (first probe set), Interpretation and report 88271x2-DNA probe, each; each additional probe set (if appropriate) 88271x1-DNA probe, each; coverage for sets containing 3 probes (if appropriate) 88271x2-DNA probe, each; coverage for sets containing 4 probes (if appropriate) 88271x3-DNA probe, each; coverage for sets containing 5 probes (if appropriate) 88274 w/modifier 52-Interphase in situ hybridization,

FGF1F

FGFR1 (8p11.2) Amplification, FISH, Tissue

88271x2, 88291-DNA probe, each (first probe set), Interpretation and report 88271x2-DNA probe, each; each additional probe set (if appropriate) 88271x1-DNA probe, each; coverage for sets containing 3 probes (if appropriate) 88271x2-DNA probe, each; coverage for sets containing 4 probes (if appropriate) 88271x3-DNA probe, each; coverage for sets containing 5 probes (if appropriate) 88274 w/modifier 52-Interphase in situ hybridization,

DBMD

Duchenne/Becker Muscular Dystrophy, DMD Gene, Large Deletion/Duplication Analysis, Varies

81161-DMD (dystrophin) (eg, Duchenne/Becker muscular dystrophy) deletion analysis and duplication analysis, if performed Fibroblast Culture for Genetic Test 88233-Tissue culture, skin or solid tissue biopsy (if appropriate) 88240-Cryopreservation (if appropriate)   Amniotic Fluid Culture/Genetic Test 88235-Tissue culture for amniotic fluid (if appropriate) 88240-Cryopreservation (if appropriate)   Maternal Cell Contamination, B 81265-Comparative analysis using Short Tandem Repeat (STR) markers; patient and comparative specimen (eg, pre-transplant recipient and donor germline testing, post-transplant non-hematopoietic recipient germline [eg, buccal swab or other germline tissue sample] and donor testing, twin zygosity testing or maternal cell contamination of fetal cells (if appropriate)

HCCDD

Hepatitis C Virus Antibody, Cadaveric or Hemolyzed Specimens, Symptomatic, Serum

86803 86804 (if appropriate)

JAKXM

JAK2 Exon 12 and Other Non-V617F Mutation Detection, Bone Marrow

0027U-JAK2 (Janus kinase 2) (eg, myeloproliferative disorder), exon 12 sequence and exon 13 sequence, if performed

RMALD

Ident by MALDI-TOF Mass Spec (Bill Only)

87077

AMLPC

Amylase, Pancreatic Cyst Fluid

82150

DOGD

Dog Dander, IgE, Serum

86003